Alnylam Pharmaceuticals, Inc. (ALNY)

364.52 -5.48 (-1.48%) USD  |  NASDAQ  |  Jan 23, 14:21
More

Alnylam Pharmaceuticals Non-Current Portion of LTD and Capital Lease Obligation (Annual)

Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks

View Non-Current Portion of LTD and Capital Lease Obligation (Annual) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade